bibliographic resource 4178430 [br/4178430]
https://w3id.org/oc/corpus/br/4178430

is a

• document
• article

title

• Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study

publication date

• 2007-01-01

contributor

• https://w3id.org/oc/corpus/ar/15950627
• https://w3id.org/oc/corpus/ar/15950628
• https://w3id.org/oc/corpus/ar/15950629
• https://w3id.org/oc/corpus/ar/15950630
• https://w3id.org/oc/corpus/ar/15950631
• https://w3id.org/oc/corpus/ar/15950632
• https://w3id.org/oc/corpus/ar/15950633
• https://w3id.org/oc/corpus/ar/15950634
• https://w3id.org/oc/corpus/ar/15950635
• https://w3id.org/oc/corpus/ar/15950636
• https://w3id.org/oc/corpus/ar/15950637
• https://w3id.org/oc/corpus/ar/15950638
• https://w3id.org/oc/corpus/ar/15950639
• https://w3id.org/oc/corpus/ar/15950640
• https://w3id.org/oc/corpus/ar/15950641
• https://w3id.org/oc/corpus/ar/15950642
• https://w3id.org/oc/corpus/ar/15950643
• https://w3id.org/oc/corpus/ar/15950644
• https://w3id.org/oc/corpus/ar/15950645
• https://w3id.org/oc/corpus/ar/15950646
• https://w3id.org/oc/corpus/ar/15950647

format

• https://w3id.org/oc/corpus/re/2348258

identifier

• https://w3id.org/oc/corpus/id/8324475
• https://w3id.org/oc/corpus/id/8324476
• https://w3id.org/oc/corpus/id/8324477

part of

• https://w3id.org/oc/corpus/br/203824